PRUDENTIAL FINANCIAL INC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 187 filers reported holding ANI PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRUDENTIAL FINANCIAL INC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,466,273
+127.2%
42,478
+110.7%
0.00%
+100.0%
Q2 2023$1,085,374
+129.8%
20,163
+69.5%
0.00%
+100.0%
Q1 2023$472,390
-4.6%
11,893
-3.3%
0.00%0.0%
Q4 2022$494,950
+23.7%
12,303
-1.2%
0.00%0.0%
Q3 2022$400,000
+0.5%
12,453
-7.3%
0.00%0.0%
Q2 2022$398,000
-19.3%
13,428
-23.4%
0.00%0.0%
Q1 2022$493,000
-33.1%
17,538
+9.7%
0.00%0.0%
Q4 2021$737,000
-15.1%
15,988
-39.6%
0.00%0.0%
Q3 2021$868,000
-40.9%
26,459
-36.8%
0.00%
-50.0%
Q2 2021$1,468,000
-40.2%
41,886
-38.3%
0.00%
-50.0%
Q1 2021$2,455,000
+100.1%
67,918
+60.8%
0.00%
+100.0%
Q4 2020$1,227,000
+256.7%
42,233
+246.7%
0.00%
+100.0%
Q3 2020$344,000
-11.6%
12,183
+1.2%
0.00%0.0%
Q2 2020$389,000
-35.7%
12,040
-19.0%
0.00%0.0%
Q1 2020$605,000
-35.0%
14,857
-1.6%
0.00%0.0%
Q4 2019$931,000
-15.7%
15,098
-0.3%
0.00%
-50.0%
Q3 2019$1,104,000
-28.6%
15,148
-19.5%
0.00%0.0%
Q2 2019$1,547,000
+17.1%
18,818
+0.4%
0.00%0.0%
Q1 2019$1,321,000
+66.2%
18,737
+6.2%
0.00%
+100.0%
Q4 2018$795,000
-24.0%
17,649
-4.6%
0.00%
-50.0%
Q3 2018$1,046,000
-21.8%
18,492
-7.6%
0.00%0.0%
Q2 2018$1,338,000
+41.6%
20,022
+23.4%
0.00%
+100.0%
Q1 2018$945,000
-2.6%
16,222
+7.8%
0.00%0.0%
Q4 2017$970,000
+21.4%
15,050
-1.2%
0.00%0.0%
Q3 2017$799,000
+22.4%
15,230
+9.2%
0.00%0.0%
Q2 2017$653,000
-6.3%
13,950
-0.9%
0.00%0.0%
Q1 2017$697,000
-17.1%
14,080
+1.4%
0.00%0.0%
Q4 2016$841,000
-13.0%
13,880
-4.7%
0.00%
-50.0%
Q3 2016$967,000
-7.4%
14,570
-22.1%
0.00%0.0%
Q2 2016$1,044,000
+68.4%
18,700
+1.6%
0.00%
+100.0%
Q1 2016$620,000
-23.7%
18,410
+2.2%
0.00%0.0%
Q4 2015$813,000
+11.8%
18,010
-2.2%
0.00%0.0%
Q3 2015$727,000
-38.4%
18,410
-3.3%
0.00%
-50.0%
Q2 2015$1,181,000
+1.9%
19,030
+2.7%
0.00%0.0%
Q1 2015$1,159,00018,5300.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Mesirow Financial Investment Management, Inc. 9,433$266,0001.14%
Global Alpha Capital Management Ltd. 258,946$7,305,0001.12%
Birch Grove Capital LP 50,791$1,433,0000.78%
1492 Capital Management LLC 25,003$705,0000.53%
INVESTMENT COUNSELORS OF MARYLAND LLC 321,975$9,083,0000.41%
THB ASSET MANAGEMENT 48,385$1,364,0000.38%
Regent Investment Management LLC 36,979$1,043,0000.32%
GLOBEFLEX CAPITAL L P 41,212$1,163,0000.31%
HUSSMAN STRATEGIC ADVISORS, INC. 35,500$1,001,0000.26%
Ranger Investment Management 124,763$3,520,0000.22%
View complete list of ANI PHARMACEUTICALS INC shareholders